Elise Landais, PhD

Assistant Professor Adjunct

Department of Immunology and Microbiology

News

Two HIV vaccine trials show proof of concept for pathway to broadly neutralizing antibodies

North American and African clinical trials led by Scripps Research, IAVI and additional collaborators across the U.S. and Africa mark progress toward an effective HIV vaccine.

News

Advancing toward a preventative HIV vaccine

Across four preclinical studies, Scripps Research, IAVI, and additional collaborators make headway in stimulating the rare antibodies needed to fight HIV.

Jon Steichen

News

Engineered immune cells elicit broad response to HIV in mice, offering hope for vaccine or functional cure

Scientists developed an approach that successfully generates antibodies against numerous strains of the fast-evolving human immunodeficiency virus.

James Voss

News

Scientists discover key element of strong antibody response to COVID-19, offering inspiration for vaccine design

Findings of the new study support many vaccine strategies currently being used to tackle the new coronavirus.

News

Super-potent human antibodies protect against COVID-19 in animal tests

A team led by Scripps Research has discovered antibodies in the blood of recovered COVID-19 patients that provide powerful protection against the coronavirus that causes the disease.

COVID-19

News

New Findings to Help HIV Scientists Establish ‘Template’ for Potent Antibodies

"Uncovering the process by which neutralizing antibodies develop is critical to HIV vaccine design."

Immunology & Microbiology Integrative Structural & Computational Biology